>>> Publicis Groupe Acquires Qorvis Communications an independent public relatio


Publicis Groupe Acquires Qorvis Communications an independent public relations firm in the US; terms not disclosed
- Counting over 80 professionals and based in Washington, D.C. Qorvis will greatly increase MSLGROUP's presence in the important market. Founded in 2000 by Managing Partner Michael Petruzzello, Qorvis counts numerous high-profile sovereign nations, organizations and global brands among its clients, such as AAMCO, Cisco Systems, The Mayo Clinic, The United States Institute for Peace and the American Pharmacists Association. While much of the firm's work is in public affairs, it also offers strong social and digital and is known for its seamless, fully integrated approach.

- As part of the Qorvis acquisition, MSLGROUP also acquires the full-service Clarus Research Group, led by Dr. Ronald A. Faucheux, Ph.D., a respected public opinion and public affairs analyst. Faucheux will also play a leadership role in MSLGROUP North America's overall planning and analytics offering.

- Qorvis' ties to numerous governments in emerging markets strengthen an important dimension of MSLGROUP's world-class global network that is already recognized as the largest of its kind in Asia, India, China and Europe.

(BFW) *SYMRISE RAISES PROBI STAKE TO 30.03%, TRIGGERS MANDATORY BID

+------------------------------------------------------------------------------+

BFW 01/10 16:19 *SYMRISE RAISES PROBI STAKE TO 30.03%, TRIGGERS MANDATORY BID BN 01/10 16:18 *SYMRISE NOW HAS TO LAUNCH MANDATORY PUBLIC OFFER FOR PROBI BN 01/10 16:17 *SYMRISE STAKE IN PROBI INCREASED TO 30.03% BN 01/10 16:17 *SYMRISE ROSE BOOSTED IN PROBI TO 30.03%

+------------------------------------------------------------------------------+

DGAP-News: Symrise AG has increased its holdings in Probi to 30.03 per cent, which gives rise to an obligation to launch a 2014-01-10 16:16:52.791 GMT

DGAP-News: Symrise AG has increased its holdings in Probi to 30.03 per cent, which gives rise to an obligation to launch a mandatory public offer

DGAP-News: Symrise AG / Key word(s): Investment Symrise AG has increased its holdings in Probi to 30.03 per cent, which gives rise to an obligation to launch a mandatory public offer

10.01.2014 / 17:16

>>> EuroHedge Awards 2013 -23/01/2014

**** NOMINATION ****

EUROPEAN EQUITY – over $500m
Adelphi Europe
Antares European
BlackRock European
Dabroes
Horseman European Select
MW European TOPS
Pelham Long/Short
TT Mid-Cap Europe Long Short


EUROPEAN EQUITY – under $500m
AlphaGen Tucana
LAE Fund
Lucerne Capital
Madrague Equity Long/Short
Martin Currie European
Pegasus
RWC Samsara
Sphera

GLOBAL EQUITY – over $500m
Egerton
Hengistbury
Lansdowne Developed Markets
MW Eureka
Oceanic
The Children’s Investment Fund

GLOBAL EQUITY – under $500m
Farringdon Alpha One
Horseman Global
Jabcap Global Balanced
Kinsale Compass
Parus

SPECIALIST EQUITY
AlphaGen Octanis
Cazenove UK Dynamic
Ennismore European Smaller Companies
Lansdowne Global Financials
Nordic Alpha
Rhenman Healthcare Equity Long/Short
Tosca Mid-Cap


EMERGING MARKET EQUITY
36ONE Offshore
Adelphi Emerging Europe
Carrhae Capital
Laurium Offshore
PCP Emerging Markets Active
Visio IV South Africa Long/Short


EQUITY MARKET NEUTRAL & QUANTITATIVE STRATEGIES
Abaco Financials
BlackRock Eos
CZ Equilibria
GSA Capital International
GSA QFF
LMR Fund
MW Market Neutral TOPS
Sector Healthcare


CONVERTIBLES & VOLATILITY
Boussard & Gavaudan Fund
Brennus
GLG Global Convertible Bond
Jabcap Global Convertible
Polygon Convertible Opportunity


EVENT DRIVEN & DISTRESSED
Alcentra Global Special Situations
Cheyne European Event-Driven
GLG European Distressed
King Street Europe
Polygon European Equity Opportunity
Tosca Opportunity
York European Opportunities


FIXED INCOME
Asgard Fixed Income
BlackRock Fixed Income Global Alpha
Brummer & Partners Nektar
Capula Global Relative Value
Danske Invest Hedge Fixed Income Strategies
Midgard Fixed Income
Pelagus Capital
Sanctum Fixed Income


CREDIT
Capeview Recovery
Cheyne Corporate Loan
Cheyne Total Return Credit
Gladwyne
Napier Park Global Credit Opportunities
WB Opportunities

SPECIALIST CREDIT
Alcentra Structured Credit Opportunity
Chenavari Toro Capital IA
Chenavari Regulatory Capital
Cheyne High Income Regulatory Capital
Cheyne Real Estate Credit Holdings
Coriolis Catpricorn
Securis I

EMERGING MARKETS
BlackRiver EMEA Investors
BlueCrest Emerging Markets
Finisterre Sovereign Debt
GIB Emerging Markets Opportunities
Pharo Trading
VR Global Offshore


MACRO
ABD Investment Tactical Discretionary Macro
BTG Pactual Global Emerging Markets and Macro
CDAM Global Opportunities
Macrosynergy Trading
North MaxQ Macro
Pharo Macro
Stone Milliner Macro


MANAGED FUTURES, COMMODITY & CURRENCY
Alder Global 20
Amplitude Dynamic Trading
Brummer & Partners Lynx
Cumulus Energy
Man AHL Evolution
PGR Capital Systematic Strategies
Quantica Managed Futures
Winton Futures


MIXED ARBITRAGE & MULTI-STRATEGY
AlphaGen Perseus
Brummer & Partners Carve
Cheyne Multi-Strategy
Chenavari Multi-Strategy
CQS Directional Opportunities
GLG Market Neutral
Jabcap Multi-Strategy
Portland Hill Overseas


EMERGING MANAGER & SMALLER FUND
Alken Capital One
AlphaGen UK Small Cap Best Ideas
Helium Special Situations
IMC Quantitative Indicator
Inflection Point Investments
Ironshield Special Situations
OneWall Global
Ovington
Tosca Focus


UCITS FUND
Catella Nordic Corporate Bond
CF Odey Absolute Return
Cheyne Convertibles Absolute Return
MLIS Och-Ziff Multi-Strategy
MS Algebris Global Financials
Odey Odyssey
Old Mutual Global Equity Absolute Return
XAIA Credit Basis


NEW FUND OF THE YEAR – EQUITY STRATEGIES
AlphaGen Volantis Catalyst
Covalis Capital
Macquarie European Alpha
Sabre Global Opportunities
Silvaris


NEW FUND OF THE YEAR – MACRO, FIXED INCOME & RELATIVE VALUE
ABD Investment Tactical Discretionary Macro
Andurand Commodities
Brummer & Partners Carve
Cheyne Multi-Strategy
Eyck European Tactical Distressed Opportunities


LONG TERM PERFORMANCE - EQUITY STRATEGIES (5 years)
AlphaGen Volantis
GSA Capital International
MW Eureka
OCCO Eastern European
Pelham Long/Short
Polar Capital European Forager
The Children’s Investment Fund


LONG TERM PERFORMANCE – MACRO, FIXED INCOME & RELATIVE VALUE (5 years)
BlackRock Fixed Income Global Alpha
BTG Pactual Global Emerging Markets and Macro
Capula Global Relative Value
CQS Directional Opportunities
Danske Invest Hedge Fixed Income Strategies
GLG Market Neutral
Securis I
VR Global Offshore


MANAGEMENT FIRM OF THE YEAR
Chenavari
Cheyne Capital
Henderson AlphaGen
Jabre Capital
Lansdowne Partners
Marshall Wace

(BFW) Actavis Seen Merging With Teva, Mylan or Novartis: Cowen

+------------------------------------------------------------------------------+

Actavis Seen Merging With Teva, Mylan or Novartis: Cowen 2014-01-10 14:57:50.988 GMT

By Catherine Larkin Jan. 10 (Bloomberg) -- Actavis ultimately will combine with Teva, Mylan or Novartis as generic-drug industry faces significant consolidation of suppliers, Cowen analyst Ken Cacciatore says in note. * Says ACT will continue to consolidate complementary businesses and create value in the interim “to better dictate terms upon their own exit” * Sees Meda, Salix, Galderma as acquisition candidates for ACT * Upgrades ACT to outperform from market perform, PT raised to $215 from $130 (vs Bloomberg avg $186) * NOTE: Earlier, Valeant Seen With ‘Most Urgency’ in Specialty Pharma M&A: Susquehanna * NOTE: From Jan. 8, Morgan Stanley Says Specialty Pharma Consolidation Will Continue

For Related News and Information: First Word scrolling panel: FIRST<GO> First Word newswire: NH BFW<GO>

To contact the reporter on this story: Catherine Larkin in Chicago at +1-312-443-5968 or clarkin4@bloomberg.net

To contact the editor responsible for this story: Joanna Ossinger at +1-212-617-7789 or jossinger@bloomberg.net

Summary re NFP so far - we believe market looks to buy the dip USD and Equities

Summary re NFP so far - we believe market looks to buy the dip USD and Equities with picture so muddied

US NFP 74k VERY WEAK
Expected at 197k vs 203k prev

Unemploymentr Rate MUCH BETTER @ 6.7% vs 7.0% expected

Most not working due to weather at 273,000 most since 1970's -

INTOUCHFX VIEW: We feel market looks to sell the rally.. such a confusing picture ... EURUSD looks a good sell at 1.3650.. market was in mood to buy USD ahead of it.. think they discount the headline .. write it off to weather.. and try get the dollars in cheap here

We think you buy the dip in equities and this backed up here... Market was looking to buy ahead of the data.. it's not great but the picture is so confusing we believe market will go back to what they know and how they felt before.. Will be sensitive to any comments from the Fed however, and we believe in particular that comments on extending forward guidance / lowering unemployment threshold could be crucial


Goldies saying its a very strange report.. with Hatzius looking at weaker side to earnings He feels weather accounts for 50k or so, but still a large gap to account for Upward revisions but not huge so hard to know what accounts for such a large affect


UBS on NFP Breakdown: Based on the weaker weather-related
payrolls data plus some household-survey data on not at work
because of weather, we would estimate the weather drag on Dec
payrolls to be about 45k. So still some underlying softening in
payrolls, but the temporary drag from weather was also
noticeable. That weather drag is of course likely to be
exacerbated by the cold patch in January.
Note: *More than a quarter million Americans were not at work
because of inclement weather, the most for any December since
1997*
USTs: Seems to be behind some of the give back in TYh here.